gleevec Pill - orange capsule/oblong, 19mm

Generic Name: imatinib

Pill with imprint gleevec is Orange, Capsule/Oblong and has been identified as Gleevec 400 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Gleevec is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Dermatofibrosarcoma Protuberans; Chronic Eosinophilic Leukemia; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Gleevec 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for gleevec

Gleevec

Generic Name: imatinib
Imprint: gleevec
Strength: 400 mg
Color: Orange
Size: 19.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Novartis Pharmaceuticals Corporation
National Drug Code (NDC): 00078-0649
Inactive Ingredients: silicon dioxide, crospovidone, ferric oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol 4000, magnesium silicate, hypromelloses, ferric oxide yellow, water
Note: Inactive ingredients may vary.